Focal sharp waves are a specific early-stage marker of the MM2-cortical form of sporadic Creutzfeldt-Jakob disease.


Journal

Prion
ISSN: 1933-690X
Titre abrégé: Prion
Pays: United States
ID NLM: 101472305

Informations de publication

Date de publication:
12 2020
Historique:
entrez: 14 8 2020
pubmed: 14 8 2020
medline: 1 10 2021
Statut: ppublish

Résumé

Periodic sharp wave complexes (PSWCs), identified using electroencephalography, are observed in less than half of patients with the methionine homozygosity type 2 cortical (MM2c) form of sporadic Creutzfeldt-Jakob disease (sCJD), and only at a later stage of the disease. In this study, we identified early and specific markers on the electroencephalograms (EEGs) of patients with MM2c-sCJD. We retrospectively investigated the clinical records, EEGs, and magnetic resonance imaging (MRI) scans of patients diagnosed with sCJD and compared the EEG findings of MM2c-sCJD and MM1/classic sCJD groups. The records of six patients with MM2c-sCJD and eight with MM1/classic sCJD were included. The median ages of onset in the MM2c- and MM1/classic sCJD groups were 75.0 (range, 60-83) and 72.5 (range, 51-74) years, respectively, and the average durations between disease onset and the first EEG were 9.17 (range, 4-15) and 1.88 (range, 1-4) months, respectively. Focal sharp waves and/or focal spike-and-wave complexes in the brain regions corresponding with cortical hyperintensities on MRI scans were identified on the EEGs of patients with MM2c-sCJD in the early stages of disease progression. In contrast, EEGs of patients in the early stages of MM1/classic sCJD showed lateralized or generalized diffuse sharp waves and spike-and-wave complexes, which were not limited to cortical hyperintensities identified with MRI scans. Our findings indicate that focal sharp waves and/or focal spike-and-wave complexes on the EEGs of patients in the early phase of MM2c-sCJD are characteristic of the disease, suggesting the possible usefulness of this characteristic for early diagnosis.

Identifiants

pubmed: 32787547
doi: 10.1080/19336896.2020.1803516
pmc: PMC7518755
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

207-213

Références

Neurology. 2002 Jan 22;58(2):192-7
pubmed: 11805244
Clin Neurol Neurosurg. 2010 Jul;112(6):537-40
pubmed: 20430517
Brain Pathol. 1998 Jul;8(3):499-513
pubmed: 9669700
SAGE Open Med Case Rep. 2017 Dec 11;5:2050313X17744482
pubmed: 29276596
Clin Neurophysiol. 2004 Nov;115(11):2467-78
pubmed: 15465434
Neurology. 2009 Apr 21;72(16):1425-31
pubmed: 19380702
Neurology. 2004 Aug 10;63(3):436-42
pubmed: 15304573
J Neurol Neurosurg Psychiatry. 2018 May;89(5):461-466
pubmed: 29142140
Dement Geriatr Cogn Disord. 2005;19(5-6):324-30
pubmed: 15785033
Arch Neurol. 1981 May;38(5):312-4
pubmed: 7013738
Arch Neurol. 2006 Jun;63(6):876-80
pubmed: 16769870
J Clin Neurophysiol. 2008 Feb;25(1):25-31
pubmed: 18303557
Prion. 2019 Jan;13(1):124-131
pubmed: 31219399
Ann Neurol. 2000 Sep;48(3):323-9
pubmed: 10976638
Ann Neurol. 1979 Feb;5(2):177-88
pubmed: 371520
Neurology. 2005 Feb 22;64(4):643-8
pubmed: 15728285
Ann Neurol. 1999 Aug;46(2):224-33
pubmed: 10443888
Clin Neurophysiol. 2004 Feb;115(2):316-9
pubmed: 14744571
Neurosurg Focus. 2015 Nov;39(5):E2
pubmed: 26646926
Neurol Sci. 2011 Aug;32(4):719-22
pubmed: 21556866
Epilepsy Behav Case Rep. 2019 Jan 26;11:77-80
pubmed: 30788213
Brain. 2009 Oct;132(Pt 10):2643-58
pubmed: 19734292
PLoS One. 2013;8(3):e60003
pubmed: 23555862
Arch Neurol. 1996 Feb;53(2):162-6
pubmed: 8639066
J Neurol Sci. 2015 Jan 15;348(1-2):274-6
pubmed: 25433451
Int J Mol Sci. 2011;12(9):6281-92
pubmed: 22016658
Biochem Biophys Res Commun. 2018 Feb 19;496(4):1055-1061
pubmed: 29382530
J Alzheimers Dis. 2015;50(2):465-76
pubmed: 26682685
J Neurol Sci. 2015 Dec 15;359(1-2):424-9
pubmed: 26478131
Brain. 2010 Oct;133(10):3043-57
pubmed: 20855418
Arch Neurol. 1980 Mar;37(3):143-5
pubmed: 6986863

Auteurs

Taiki Matsubayashi (T)

Department of Neurology and Neurological Science, Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences , Tokyo, Japan.

Miho Akaza (M)

Respiratory and Nervous System Science, Biomedical Laboratory Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University , Tokyo, Japan.

Yuichi Hayashi (Y)

Department of Neurology, Gifu University Graduate School of Medicine , Gifu, Japan.

Tsuyoshi Hamaguchi (T)

Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Science , Kanazawa, Japan.

Masahito Yamada (M)

Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Science , Kanazawa, Japan.

Takayoshi Shimohata (T)

Department of Neurology, Gifu University Graduate School of Medicine , Gifu, Japan.

Takanori Yokota (T)

Department of Neurology and Neurological Science, Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences , Tokyo, Japan.

Nobuo Sanjo (N)

Department of Neurology and Neurological Science, Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences , Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH